Your browser doesn't support javascript.
loading
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
Schaeffer, Edward M; Srinivas, Sandy; Adra, Nabil; An, Yi; Barocas, Daniel; Bitting, Rhonda; Bryce, Alan; Chapin, Brian; Cheng, Heather H; D'Amico, Anthony Victor; Desai, Neil; Dorff, Tanya; Eastham, James A; Farrington, Thomas A; Gao, Xin; Gupta, Shilpa; Guzzo, Thomas; Ippolito, Joseph E; Kuettel, Michael R; Lang, Joshua M; Lotan, Tamara; McKay, Rana R; Morgan, Todd; Netto, George; Pow-Sang, Julio M; Reiter, Robert; Roach, Mack; Robin, Tyler; Rosenfeld, Stan; Shabsigh, Ahmad; Spratt, Daniel; Teply, Benjamin A; Tward, Jonathan; Valicenti, Richard; Wong, Jessica Karen; Berardi, Ryan A; Shead, Dorothy A; Freedman-Cass, Deborah A.
  • Schaeffer EM; 1Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Srinivas S; 2Stanford Cancer Institute.
  • Adra N; 3Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
  • An Y; 4Yale Cancer Center/Smilow Cancer Hospital.
  • Barocas D; 5Vanderbilt-Ingram Cancer Center.
  • Bitting R; 6Duke Cancer Institute.
  • Bryce A; 7Mayo Clinic Cancer Center.
  • Chapin B; 8The University of Texas MD Anderson Cancer Center.
  • Cheng HH; 9Fred Hutchinson Cancer Center.
  • D'Amico AV; 10Dana-Farber/Brigham and Women's Cancer Center.
  • Desai N; 11UT Southwestern Simmons Comprehensive Cancer Center.
  • Dorff T; 12City of Hope National Cancer Center.
  • Eastham JA; 13Memorial Sloan Kettering Cancer Center.
  • Farrington TA; 14Prostate Health Education Network (PHEN).
  • Gao X; 15Massachusetts General Hospital Cancer Center.
  • Gupta S; 16Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Guzzo T; 17Abramson Cancer Center at The University of Pennsylvania.
  • Ippolito JE; 18Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Kuettel MR; 19Roswell Park Comprehensive Cancer Center.
  • Lang JM; 20University of Wisconsin Carbone Cancer Center.
  • Lotan T; 21The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • McKay RR; 22UC San Diego Moores Cancer Center.
  • Morgan T; 23University of Michigan Rogel Cancer Center.
  • Netto G; 24O'Neal Comprehensive Cancer Center at UAB.
  • Pow-Sang JM; 25Moffitt Cancer Center.
  • Reiter R; 26UCLA Jonsson Comprehensive Cancer Center.
  • Roach M; 27UCSF Helen Diller Family Comprehensive Cancer Center.
  • Robin T; 28University of Colorado Cancer Center.
  • Rosenfeld S; 29University of California San Francisco Patient Services.
  • Shabsigh A; 30The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.
  • Spratt D; 16Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Teply BA; 31Fred & Pamela Buffett Cancer Center.
  • Tward J; 32Huntsman Cancer Institute at the University of Utah.
  • Valicenti R; 33UC Davis Comprehensive Cancer Center.
  • Wong JK; 34Fox Chase Cancer Center; and.
  • Berardi RA; 35National Comprehensive Cancer Network.
  • Shead DA; 35National Comprehensive Cancer Network.
  • Freedman-Cass DA; 35National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 20(12): 1288-1298, 2022 12.
Article en En | MEDLINE | ID: mdl-36509074
ABSTRACT
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate Cancer Panel meets annually to reevaluate and update their recommendations based on new clinical data and input from within NCCN Member Institutions and from external entities. These NCCN Guidelines Insights summarizes much of the panel's discussions for the 4.2022 and 1.2023 updates to the guidelines regarding systemic therapy for metastatic prostate cancer.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Qualitative_research / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Qualitative_research / Risk_factors_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article